Review Article

Acupuncture and Moxibustion for Peripheral Neuropathic Pain: A Frequentist Network Meta-Analysis and Cost-Effectiveness Evaluation

Table 3

Characteristics summary of included studies.

AuthorRegionDiagnosisAssessment toolArmsInterventionPain durationParticipantsDropFemale/maleResponder/totalTreatment duration

Chen et al. [18]ChinaSciaticaPain threshold3G1: warm needlingG1: 5.25 ± 3.59 yG1: 30G1: 0G1: 8/22G1: 27/3010 d
G2: nimesulide dispersible tabletsG2: 5.78 ± 4.87 yG2: 30G2: 0G2: 9/21G2: 22/30
G3: acupoint injectionG3: 4.71 ± 3.96 yG3: 30G3: 0G3: 10/20G3: 19/30

Chen et al. [19]ChinaPHNVAS2G1: normal acupunctureG1: 1.35 ± 0.37 yG1: 45G1: 0G1: 16/29G1: 36/4520 d
G2: fire needlingG2: 1.42 ± 0.39 yG2: 45G2: 0G2: 14/31G2: 43/45

Gao [20]ChinaShinglesVAS2G1: electrical needlingG1: 3.32 ± 1.21 yG1: 40G1: 0G1: 16/24G1: 40/4010 d
G2: indometacin enteric-coated tabletsG2: 3.12 ± 1.43 yG2: 40G2: 0G2: 15/25G2: 34/40

Han [21]ChinaCervical entrapment syndromeVAS2G1: acupotomy (round-sharp needling)G1: 3 m–11 yG1: 68G1: 0G1: 27/41G1: 66/6814 d
G2: normal acupunctureG2: 5 m–12 yG2: 67G2: 0G2: 28/39G2: 67/67

Hong [22]ChinaOccipital neuralgiaVAS2G1: fire needlingG1: 3.8 ± 1.6 dG1: 30G1: 0G1: 16/14G1: 30/305 d
G2: carbamazepine tabletsG2: 3.7 ± 1.8 dG2: 27G2: 0G2: 15/12G2: 21/27

Li et al. [23]ChinaPHNVAS2G1: moxibustionG1: 5.90 ± 1.44 mG1: 40G1: 0G1: 17/23G1: 39/4030 d
G2: fire needlingG2: 6.07 ± 1.27 mG2: 40G2: 1G2: 18/22G2: 39/39

Li [24]ChinaPHNVAS2G1: indometacin enteric-coated tabletsG1: 4.05 ± 2.13 mG1: 42G1: 0G1: 15/27G1: 28/4215 d
G2: normal acupunctureG2: 4.13 ± 2.22 mG2: 42G2: 0G2: 16/26G2: 36/42

Lin et al. [25]ChinaPHNVAS2G1: moxibustionG1: 5.90 ± 1.44 mG1: 30G1: 1G1: 13/17G1: 28/2928 d
G2: ibuprofen sustained release capsulesG2: 6.07 ± 1.27 mG2: 30G2: 3G2: 16/14G2: 19/27

Liu [26]ChinaPHNVAS2G1: indometacin enteric-coated tabletsG1: 4.11 ± 1.69 mG1: 40G1: 0G1: 18/22G1: 32/4015 d
G2: normal acupunctureG2: 4.12 ± 1.61 mG2: 40G2: 0G2: 17/23G2: 38/40

Wang et al. [27]ChinaPHNVAS2G1: fire needlingG1: 1–10 mG1: 28G1: 0G1: 12/16G1: 28/2814 d
G2: normal acupunctureG2: 1–11 mG2: 28G2: 0G2: 13/15G2: 28/28

Xie and Chen [28]ChinaTrigeminal neuralgiaVAS2G1: carbamazepine tabletsG1: 9.8 ± 2.6YG1: 63G1: 0G1: 28/35G1: 47/631 m
G2: normal acupunctureG2: 9.4 ± 2.7 yG2: 63G2: 0G2: 27/36G2: 57/63

Xu and Kang [29]ChinaOccipital neuralgiaSF-MPQ2G1: moxibustionNAG1: 20G1: 0NAG1: 20/2010 d
G2: normal acupunctureG2: 20G2: 0G2: 18/20

Xu [30]ChinaPHNVAS2G1: fire needling26 d–3 yG1: 44G1: 0Total: 35/52G1: 41/4410 d
G2: normal acupunctureG2: 43G2: 0G2: 30/43

Yan et al. [31]ChinaPHNVAS2G1: fire needlingG1: 180.41 ± 25.71 dG1: 38G1: 0G1: 17/21G1: 37/3828 d
G2: diclofenac diethylamine emulgelG2: 175.50 ± 26.05 dG2: 37G2: 0G2: 17/20G2: 29/37

Zhou [32]ChinaOccipital neuralgiaVAS2G1: normal acupunctureG1: 4.13 ± 1.22 dG1: 60G1: 2G1: 33/27G1: 55/585 d
G2: nabumetone capsulesG2: 3.87 ± 1.39 dG2: 60G2: 5G2: 29/31G2: 40/55

Zhou et al. [33]ChinaCerical spondyliotic radicuolathySymptom scales2G1: warm needlingNAG1: 30G1: 0G1: 8/22G1: 30/3010 d
G2: normal acupunctureG2: 30G2: 0G2: 12/18G2: 26/30

PHN, postherpetic neuralgia; VAS, visual analogue scale; SF-MPQ, short-form McGill pain questionnaire; NSAIDs, nonsteroidal anti-inflammatory drugs; G1 or (2, 3), group 1 or (group 2, group 3); NA, not available; d, day; m, month; y, year.